Paper37545238
Upregulation of sFRP1 Is More Profound in Female than Male 5xFAD Mice and Positively Associated with Amyloid Pathology.
Macyczko JR and 9 others. J Alzheimers Dis, 2023. Cited by 12 papers, by iCite.
Cite this record
ConductScience Library. Upregulation of sFRP1 Is More Profound in Female than Male 5xFAD Mice and Positively Associated with Amyloid Pathology. Papers, record 37545238. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37545238
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alzheimer Disease | Major topic |
| Amyloid beta-Protein Precursor | Major topic |
| Animals | |
| Female | |
| Male | |
| Mice | |
| ADAM10 Protein | |
| Amyloid | |
| Amyloid beta-Peptides | |
| Amyloidogenic Proteins | |
| Aspartic Acid Endopeptidases | |
| Brain | |
| Disease Models, Animal | |
| Mice, Transgenic | |
| Up-Regulation | |
| Secreted Frizzled-Related Proteins |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R21 AG065653 | NIA NIH HHS | United States | R21AG065653 | PubMed and NIH |
Source NIH RePORTER
References26
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9343467 | Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. | JAMA | 1997 | https://conductscience.org/library/papers/9343467 | PubMed |
| 2 | 15146243 | A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model. | J Clin Invest | 2004 | https://conductscience.org/library/papers/15146243 | PubMed |
| 3 | 20619937 | Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal Aβ aggregation in the 5XFAD mouse model of Alzheimer's disease. | Neurobiol Aging | 2012 | https://conductscience.org/library/papers/20619937 | PubMed |
| 4 | 10097139 | Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease. | Proc Natl Acad Sci U S A | 1999 | https://conductscience.org/library/papers/10097139 | PubMed |
| 5 | 34687956 | Past, present and future of therapeutic strategies against amyloid-β peptides in Alzheimer's disease: a systematic review. | Ageing Res Rev | 2021 | https://conductscience.org/library/papers/34687956 | PubMed |
| 6 | 17021169 | Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. | J Neurosci | 2006 | https://conductscience.org/library/papers/17021169 | PubMed |
| 7 | 19608551 | Potential late-onset Alzheimer's disease-associated mutations in the ADAM10 gene attenuate {alpha}-secretase activity. | Hum Mol Genet | 2009 | https://conductscience.org/library/papers/19608551 | PubMed |
| 8 | 30836275 | ADAM10 in Alzheimer's disease: Pharmacological modulation by natural compounds and its role as a peripheral marker. | Biomed Pharmacother | 2019 | https://conductscience.org/library/papers/30836275 | PubMed |
| 9 | 24650793 | Exosome reduction in vivo is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer's disease. | Neurobiol Aging | 2014 | https://conductscience.org/library/papers/24650793 | PubMed |
| 10 | 29985474 | Sex differences in Alzheimer disease - the gateway to precision medicine. | Nat Rev Neurol | 2018 | https://conductscience.org/library/papers/29985474 | PubMed |
| 11 | 21478884 | SFRPs act as negative modulators of ADAM10 to regulate retinal neurogenesis. | Nat Neurosci | 2011 | https://conductscience.org/library/papers/21478884 | PubMed |
| 12 | 24055016 | ADAM10 missense mutations potentiate β-amyloid accumulation by impairing prodomain chaperone function. | Neuron | 2013 | https://conductscience.org/library/papers/24055016 | PubMed |
| 13 | 20676056 | ADAM10 is the physiologically relevant, constitutive alpha-secretase of the amyloid precursor protein in primary neurons. | EMBO J | 2010 | https://conductscience.org/library/papers/20676056 | PubMed |
| 14 | 32098349 | Enhancing α-secretase Processing for Alzheimer's Disease-A View on SFRP1. | Brain Sci | 2020 | https://conductscience.org/library/papers/32098349 | PubMed |
| 15 | 27025652 | The amyloid hypothesis of Alzheimer's disease at 25 years. | EMBO Mol Med | 2016 | https://conductscience.org/library/papers/27025652 | PubMed |
| 16 | 36215026 | Suppression of Wnt/β-Catenin Signaling Is Associated with Downregulation of Wnt1, PORCN, and Rspo2 in Alzheimer's Disease. | Mol Neurobiol | 2023 | https://conductscience.org/library/papers/36215026 | PubMed |
| 17 | 35115731 | Large-scale deep multi-layer analysis of Alzheimer's disease brain reveals strong proteomic disease-related changes not observed at the RNA level. | Nat Neurosci | 2022 | https://conductscience.org/library/papers/35115731 | PubMed |
| 18 | 21214928 | APP processing in Alzheimer's disease. | Mol Brain | 2011 | https://conductscience.org/library/papers/21214928 | PubMed |
| 19 | 31926610 | Deep Multilayer Brain Proteomics Identifies Molecular Networks in Alzheimer's Disease Progression. | Neuron | 2020 | https://conductscience.org/library/papers/31926610 | PubMed |
| 20 | 35390543 | The development of ADAM10 endocytosis inhibitors for the treatment of Alzheimer's disease. | Mol Ther | 2022 | https://conductscience.org/library/papers/35390543 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42524328 | Pharmacodynamic and stage-dependent therapeutic efficacy of SFRP1 neutralization in a mouse model of Alzheimer's disease. | Alzheimers Dement (N Y) | 2026 | https://conductscience.org/library/papers/42524328 | PubMed |
| 42185674 | Overexpression of WNT3a in the Hippocampus Can Partly Alleviate Deficits in Animal Models of Alzheimer's Disease. | Neurochem Res | 2026 | https://conductscience.org/library/papers/42185674 | PubMed |
| 42146614 | Discovery of a CI-994 derivative as a dual modulator of class I HDACs and Wnt/β- catenin signaling for Alzheimer's disease therapy. | bioRxiv | 2026 | https://conductscience.org/library/papers/42146614 | PubMed |
| 42104459 | Proteomic analysis in Alzheimer's disease and other dementias: a focus on sex-specific differences. | Alzheimers Res Ther | 2026 | https://conductscience.org/library/papers/42104459 | PubMed |
| 41840318 | Unravelling Epigenetic Modulation via MicroRNA Delivery: A Therapeutic Frontier for Alzheimer's. | Mol Neurobiol | 2026 | https://conductscience.org/library/papers/41840318 | PubMed |
| 41654970 | CI-994 is a dual modulator of class I HDACs and Wnt/β-catenin signaling for the treatment of Alzheimer's disease. | Alzheimers Res Ther | 2026 | https://conductscience.org/library/papers/41654970 | PubMed |
| 39447490 | Amyloid pathology and cognitive impairment in hAβ-KI and APPSAA-KI mouse models of Alzheimer's disease. | Neurobiol Aging | 2025 | https://conductscience.org/library/papers/39447490 | PubMed |
| 39269584 | Activation of the muscle-to-brain axis ameliorates neurocognitive deficits in an Alzheimer's disease mouse model via enhancing neurotrophic and synaptic signaling. | Geroscience | 2025 | https://conductscience.org/library/papers/39269584 | PubMed |
| 39167347 | Age- and Sex-Associated Wnt Signaling Dysregulation is Exacerbated from the Early Stages of Neuropathology in an Alzheimer's Disease Model. | Neurochem Res | 2024 | https://conductscience.org/library/papers/39167347 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ADAM10 | 102 | PubTator's text mining | https://conductscience.org/library/genes/102 | NCBI Gene |
| APP | 351 | PubTator's text mining | https://conductscience.org/library/genes/351 | NCBI Gene |
| SFRP1 | 6422 | PubTator's text mining | https://conductscience.org/library/genes/6422 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37545238
GET https://conductscience.org/api/papers/v1/37545238/references?page=2